SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: EepOpp who wrote (453)12/19/1997 5:57:00 PM
From: John Carragher  Respond to of 1580
 
Merk dropped 3 1/8 to 102. Friday is the deadline for the Food and Drug
Administration to take action on the marketing application for the Whitehouse
Station, N.J., drug giant's Propecia drug, the first prescription tablet for
treating male baldness. But approval may be delayed for several weeks while
the FDA and Merck negotiate the final details of the drug's labeling.



To: EepOpp who wrote (453)12/20/1997 5:30:00 AM
From: Alfred W. Post  Read Replies (2) | Respond to of 1580
 
On second thought: When a question on the Merck thread is asked, is it not natural that one answers it on that thread, after all there is a provision for reply!! But thanks for the direction - I found it and there is surprisinglg lots on it. As you can see I used it also. So no offence, please. yours Fred from Switzerland


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News